ATE217611T1 - Verfahren zur herstellung von phosphodiesterase iv inhibitoren - Google Patents

Verfahren zur herstellung von phosphodiesterase iv inhibitoren

Info

Publication number
ATE217611T1
ATE217611T1 AT97942446T AT97942446T ATE217611T1 AT E217611 T1 ATE217611 T1 AT E217611T1 AT 97942446 T AT97942446 T AT 97942446T AT 97942446 T AT97942446 T AT 97942446T AT E217611 T1 ATE217611 T1 AT E217611T1
Authority
AT
Austria
Prior art keywords
alkyl
aryl
alkenyl
group
phosphodiesterase
Prior art date
Application number
AT97942446T
Other languages
English (en)
Inventor
Ilias K Dorziotis
Ioannis N Houpis
Jaemoon Lee
Ralph P Volante
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9625819.9A external-priority patent/GB9625819D0/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of ATE217611T1 publication Critical patent/ATE217611T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyridine Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT97942446T 1996-09-17 1997-09-12 Verfahren zur herstellung von phosphodiesterase iv inhibitoren ATE217611T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2625096P 1996-09-17 1996-09-17
GBGB9625819.9A GB9625819D0 (en) 1996-12-12 1996-12-12 Method of preparing phosphodiesterase IV inhibitors
PCT/US1997/016171 WO1998012178A1 (en) 1996-09-17 1997-09-12 Method of preparing phosphodiesterase iv inhibitors

Publications (1)

Publication Number Publication Date
ATE217611T1 true ATE217611T1 (de) 2002-06-15

Family

ID=26310609

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97942446T ATE217611T1 (de) 1996-09-17 1997-09-12 Verfahren zur herstellung von phosphodiesterase iv inhibitoren

Country Status (7)

Country Link
EP (1) EP0931066B1 (de)
JP (1) JP2001501927A (de)
AT (1) ATE217611T1 (de)
AU (1) AU712869B2 (de)
CA (1) CA2265826A1 (de)
DE (1) DE69712631D1 (de)
WO (1) WO1998012178A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005043337A1 (de) * 2005-09-12 2007-03-15 Ludwig-Maximilians-Universität München Nickel- oder Eisen-katalysierte Kohlenstoff-Kohlenstoff-Kupplungsreaktion von Arylenen, Alkenen und Alkinen
EP2022783A1 (de) 2007-08-08 2009-02-11 CHIESI FARMACEUTICI S.p.A. 1-Phenyl-2-Pyridinylalkyl-Alkoholderivate als Phosphodiesterasehemmer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW263495B (de) * 1992-12-23 1995-11-21 Celltech Ltd
GB9304920D0 (en) * 1993-03-10 1993-04-28 Celltech Ltd Chemical compounds
GB9326173D0 (en) * 1993-12-22 1994-02-23 Celltech Ltd Chemical compounds and process
AR006550A1 (es) * 1996-04-17 1999-09-08 Merck & Co Inc Metodo de preparacion de inhibidores de fosfodiesterasa iv

Also Published As

Publication number Publication date
AU4414297A (en) 1998-04-14
AU712869B2 (en) 1999-11-18
EP0931066B1 (de) 2002-05-15
WO1998012178A1 (en) 1998-03-26
JP2001501927A (ja) 2001-02-13
CA2265826A1 (en) 1998-03-26
EP0931066A1 (de) 1999-07-28
DE69712631D1 (de) 2002-06-20

Similar Documents

Publication Publication Date Title
ATE174589T1 (de) Verfahren zur herstellung von piperidinderivaten
ATE410412T1 (de) Oxopyrrolidin verbindungen, verfahren zur herstellung dieser verbindungen und deren verwendung zur herstellung von levetiracetam und analogen
DE69838146D1 (de) Androgene steroidderivate und ein verfahren zur herstellung und verwendung derselben
DE69915713D1 (de) Verfahren zur herstellung von citalopram
PT71773B (de) Verfahren zur herstellung von substituierten oxirancarbonsauren
DE60219501D1 (de) Verfahren zur herstellung von 3-hydroxy-n-1,6-trialkyl-4-oxo-1,4-dihydropyridin-2-carboxamide
ATE197150T1 (de) Verfahren zur herstellung von dihydroxypyrimidin- derivaten
ATE217611T1 (de) Verfahren zur herstellung von phosphodiesterase iv inhibitoren
DE69911430D1 (de) Verfahren zur herstellung von 1-(1h)-benzoquinolizin-3-on derivaten
ATE540934T1 (de) Verfahren zur herstellung substituierter anilinverbindungen
ATE114317T1 (de) Verfahren zur herstellung von 10-g(b)-h- steroiden.
ATE208378T1 (de) Verfahren zur herstellung von nicotinsäuren
DE69702644D1 (de) Verfahren zur Herstellung von Alkylimidazolidinon(meth)acrylates
ATE272637T1 (de) Verfahren zur herstellung einer substituierten imidazopyridinverbindung
ATE299851T1 (de) Verfahren zur herstellung von zwischenprodukten
ATE241594T1 (de) N-phenylacetoacetamide und verfahren zu ihrer herstellung
DE59507361D1 (de) Cyclohexan-Derivate, Verfahren zu ihrer Herstellung und die Verwendung als Glukose-6-Phosphatase Inhibitoren
DE69619402D1 (de) Verfahren zur herstellung von methoximinophenylglyoxylsäure-derivaten
DE69515770D1 (de) Verfahren zur Produktion von Thiophospholipiden des Aether-Typs
AT387214B (de) Verfahren zur herstellung neuer n-substituierter, estergruppen enthaltender acrylamide
ATE227289T1 (de) Verfahren zur herstellung von azyklischen nukleosiden
AR000394A2 (es) Preparación de intermediarios de beta-metil carbapenem y compuestos intermediarios para su exclusivouso en dicha preparación
ATE217316T1 (de) Verfahren zur herstellung von diphosphonat- derivaten
ATE272618T1 (de) Verfahren zur herstellung von s-alkylcysteinen
ATE15484T1 (de) Verfahren zur herstellung der 3-methyl-3hydroxyglutars|ure und ein zwischenprodukt zu ihrer herstellung.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties